Recent publications by Researchers affiliated with the Centre for Tropical Medicine and Global Health
Correction to: The use of ultrasensitive quantitative-PCR to assess the impact of primaquine on asymptomatic relapse of Plasmodium vivax infections: a randomized, controlled trial in Lao PDR
Phommasone K. et al, (2020), Malaria Journal, 19
Genetic analysis of the orthologous crt and mdr1 genes in Plasmodium malariae from Thailand and Myanmar
Pimpat Y. et al, (2020), Malaria Journal, 19
Molecular epidemiology of resistance to antimalarial drugs in the Greater Mekong subregion: an observational study
Imwong M. et al, (2020), The Lancet Infectious Diseases, 20, 1470 - 1480
The use of ultrasensitive quantitative-PCR to assess the impact of primaquine on asymptomatic relapse of Plasmodium vivax infections: a randomized, controlled trial in Lao PDR
Phommasone K. et al, (2020), Malaria Journal, 19
The characterization of extracellular vesicles-derived microRNAs in Thai malaria patients.
Ketprasit N. et al, (2020), Malaria journal, 19
Polymorphisms in Plasmodium vivax antifolate resistance markers in Afghanistan between 2007 and 2017.
Rakmark K. et al, (2020), Malaria Journal, 19
Multiplex Human Malaria Array: Quantifying Antigens for Malaria Rapid Diagnostics.
Jang IK. et al, (2020), The American journal of tropical medicine and hygiene, 102, 1366 - 1369
Utility of Plasmodium falciparum DNA from rapid diagnostic test kits for molecular analysis and whole genome amplification.
Srisutham S. et al, (2020), Malaria journal, 19
Functional and structural analysis of double and triple mutants reveals the contribution of protein instability to clinical manifestations of G6PD variants.
Praoparotai A. et al, (2020), International journal of biological macromolecules, 158, 884 - 893
Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial
van der Pluijm RW. et al, (2020), The Lancet, 395, 1345 - 1360
Molecular characterization of Plasmodium falciparum antifolate resistance markers in Thailand between 2008 and 2016.
Sugaram R. et al, (2020), Malaria journal, 19
Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: Findings from randomised controlled trials
Phommasone K. et al, (2020), PLOS ONE, 15, e0228190 - e0228190
Polymorphic markers for identification of parasite population in Plasmodium malariae.
Mathema VB. et al, (2020), Malaria journal, 19
Genome-wide microsatellite characteristics of five human Plasmodium species, focusing on Plasmodium malariae and P. ovale curtisi.
Mathema VB. et al, (2020), Parasite (Paris, France), 27
Author Correction: The temporal dynamics and infectiousness of subpatent Plasmodium falciparum infections in relation to parasite density
Slater HC. et al, (2019), Nature Communications, 10
Polymorphisms in Pvkelch12 and gene amplification of Pvplasmepsin4 in Plasmodium vivax from Thailand, Lao PDR and Cambodia
Duanguppama J. et al, (2019), Malaria Journal, 18
Resolving the cause of recurrent Plasmodium vivax malaria probabilistically
Taylor AR. et al, (2019), Nature Communications, 10
The probability of a sequential Plasmodium vivax infection following asymptomatic Plasmodium falciparum and P. vivax infections in Myanmar, Vietnam, Cambodia, and Laos
von Seidlein L. et al, (2019), Malaria Journal, 18
Utility of qSOFA and modified SOFA in severe malaria presenting as sepsis
Teparrukkul P. et al, (2019), PLOS ONE, 14, e0223457 - e0223457